Ontario pauses safer supply rules as Northern communities confront deadly drug crisis

By Jacqueline St.Pierre, Local Journalism Initiative Reporter, The Manitoulin Expositor As Ontario’s medical regulator pauses new prescribing requirements, a drug poisoning warning and a push to put naloxone beside defibrillators highlight the stakes for Sudbury and Manitoulin. SUDBURY—Public Health Sudbury and Districts warned on November 5 of a rise in drug poisonings and unexpected reactions across the Sudbury and Manitoulin districts. People experienced heavy sedation, confusion and memory loss. The cause of the increase remains unknown, but public health officials warned that unregulated drugs can contain fentanyl, carfentanil or sedatives such as benzodiazepines, xylazine and medetomidine. The warning came as new figures from Ontario’s coroner showed that 36 people died of opioid toxicity in Greater Sudbury in the first six months of 2026. At 38.20 deaths per 100,000 residents, the…

This content is for Yearly Subscription, Yearly Subscription – Corporate, Print Subscription Only, Canada Print and Online, and USA Print and Online members only.
Register
Already a member? Log in here

Add Your Voice

Is there more to this story? We'd like to hear from you about this or any other stories you think we should know about. Contribute your voice on our contribute page.